Vistagen Therapeutics, Inc. (VTGN)
NASDAQ: VTGN · Real-Time Price · USD
2.560
-0.050 (-1.92%)
Nov 21, 2024, 1:14 PM EST - Market open
Vistagen Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for VTGN stock has a target of 15, which predicts an increase of 485.94% from the current stock price of 2.56.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 7, 2023.
Analyst Ratings
According to 1 stock analyst, the rating for VTGN is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '23 | Aug '23 | Sep '23 | Oct '23 | Nov '23 | Dec '23 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 1 | 1 | 1 | 2 | 1 |
Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Hold | 2 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2 | 1 | 1 | 1 | 2 | 1 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Jefferies | Jefferies | Hold → Strong Buy Upgrades $0.2 → $15 | Hold → Strong Buy | Upgrades | $0.2 → $15 | +485.94% | Dec 7, 2023 |
Stifel | Stifel | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | +368.75% | Nov 14, 2023 |
Maxim Group | Maxim Group | Strong Buy Maintains $30 | Strong Buy | Maintains | $30 | +1,071.88% | Sep 5, 2023 |
Maxim Group | Maxim Group | Hold → Strong Buy Upgrades $30 | Hold → Strong Buy | Upgrades | $30 | +1,071.88% | Aug 7, 2023 |
Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 26, 2022 |
Financial Forecast
Revenue This Year
714.00K
from 1.06M
Decreased by -32.89%
Revenue Next Year
428.40K
from 714.00K
Decreased by -40.00%
EPS This Year
-1.81
from -1.52
EPS Next Year
-1.76
from -1.81
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 1.6M | 1.3M | 9.5M | ||
Avg | 714,000 | 428,400 | 7.1M | ||
Low | 294,000 | n/a | 4.9M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 48.0% | 85.3% | 2,108.5% | ||
Avg | -32.9% | -40.0% | 1,567.8% | ||
Low | -72.4% | - | 1,043.8% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.63 | -1.38 | -1.47 | ||
Avg | -1.81 | -1.76 | -1.84 | ||
Low | -1.86 | -2.53 | -2.16 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | ||
Avg | - | - | - | ||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.